Stoke Therapeutics, Inc. - Common Stock (STOK) stock analysis
STOK · Stoke Therapeutics, Inc. - Common Stock
Latest recorded price: USD 26.63
Sector and industry: Healthcare · Biotechnology
Fiscal 2025 figures: revenue growth 145.9%, free cash flow margin 24.4%, ROIC -48.9%. The model flags 1 risk signal for this company.